Scientists probe UV's hidden immune trick in skin

NCT ID NCT05020496

Ongoing Knowledge-focused Sponsor: University of Alabama at Birmingham Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jul 21, 2026 · Updated 3 times

Summary

This study looks at how ultraviolet (UV) light from the sun can weaken the immune system in human skin, which may help explain how skin cancer develops. Researchers will apply a chemical called DPCP to the skin of 70 healthy adults aged 18-35 to trigger a mild allergic reaction and measure immune responses. The goal is to uncover new details about UV's effects, not to test a treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Diphenylcyclopropenone (DPCP) applied topically
What this could lead to: If successful, this could reveal new ways UV light weakens skin immunity, potentially pointing toward future strategies to prevent skin cancer.
What could go wrong: This is a very early, small study focused on understanding mechanisms, not testing a treatment. Results may not lead to any direct medical application.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SKIN DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

skin disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SKIN DISEASES

Contacts and locations

Locations

Whitaker Clinic

Birmingham, Alabama, 35294, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.